BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 26991077)

  • 21. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
    Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
    Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pheno- and genotypic features of Epstein-Barr virus associated B-cell lymphoproliferations in peripheral T-cell lymphomas.
    Smuk G; Illés A; Keresztes K; Kereskai L; Márton B; Nagy Z; Lacza A; Pajor L
    Pathol Oncol Res; 2010 Sep; 16(3):377-83. PubMed ID: 20016960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies to CD40 prevent Epstein-Barr virus-mediated human B-cell lymphomagenesis in severe combined immune deficient mice given human peripheral blood lymphocytes.
    Murphy WJ; Funakoshi S; Beckwith M; Rushing SE; Conley DK; Armitage RJ; Fanslow WC; Rager HC; Taub DD; Ruscetti FW
    Blood; 1995 Sep; 86(5):1946-53. PubMed ID: 7544649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular markers of clonality and identity in Epstein-Barr virus-associated B-cell lymphoproliferative disease.
    Walling DM; Andritsos LA; Etienne W; Payne DA; Aronson JF; Flaitz CM; Nichols CM
    J Med Virol; 2004 Sep; 74(1):94-101. PubMed ID: 15258974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man.
    Rowe M; Young LS; Crocker J; Stokes H; Henderson S; Rickinson AB
    J Exp Med; 1991 Jan; 173(1):147-58. PubMed ID: 1845872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High frequency of EBV association and 30-bp deletion in the LMP-1 gene in CD56 lymphomas of the upper aerodigestive tract.
    Tai YC; Kim LH; Peh SC
    Pathol Int; 2004 Mar; 54(3):158-66. PubMed ID: 14989738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of Epstein-Barr virus (EBV) type and variant in spontaneous lymphoblastoid cells and Hu-SCID mouse tumours.
    Menin C; Ometto L; Veronesi A; Roncella S; Corneo B; Montagna M; Coppola V; Veronese ML; Indraccolo S; Amadori A; De Rossi A; Ferrarini M; Chieco-Bianchi L; D'Andrea E
    Mol Cell Probes; 1996 Dec; 10(6):453-61. PubMed ID: 9025083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Model of B immunoblastic lymphomas in the Hu-PBL-SCID mice].
    Chen DQ; Bai LJ; Liu QF; Cui LX; He W; Ba DN
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Jun; 25(3):294-6. PubMed ID: 12905742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr virus infection in sarcomatoid renal cell carcinoma tissues.
    Kim KH; Han EM; Lee ES; Park HS; Kim I; Kim YS
    BJU Int; 2005 Sep; 96(4):547-52. PubMed ID: 16104908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus infection in the neoplastic and nonneoplastic cells of lymphoid malignancies.
    Teramoto N; Sarker AB; Tonoyama Y; Yoshino T; Hayashi K; Takahashi K; Akagi T
    Cancer; 1996 Jun; 77(11):2339-47. PubMed ID: 8635105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the risk of lymphomagenesis in xenografts by the PCR-based detection of EBV BamHI W region in patient cancer specimens.
    Mukohyama J; Iwakiri D; Zen Y; Mukohara T; Minami H; Kakeji Y; Shimono Y
    Oncotarget; 2016 Aug; 7(31):50150-50160. PubMed ID: 27367028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fine-tuning the EBV+ hu-PBL-SCID xenogeneic chimera model using in vivo superinfection.
    Kvell K; Balogh P; Németh P
    Pathol Oncol Res; 2000; 6(4):280-6. PubMed ID: 11173661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model.
    Romero-Masters JC; Ohashi M; Djavadian R; Eichelberg MR; Hayes M; Bristol JA; Ma S; Ranheim EA; Gumperz J; Johannsen EC; Kenney SC
    PLoS Pathog; 2018 Aug; 14(8):e1007221. PubMed ID: 30125329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr virus (EBV)-infected cells were frequently but dispersely detected in T-cell lymphomas of various types by in situ hybridization with an RNA probe specific to EBV-specific nuclear antigen 1.
    Yamamoto T; Nakamura Y; Kishimoto K; Takeuchi H; Shirakata M; Mitsuya T; Hirai K
    Virus Res; 1999 Dec; 65(1):43-55. PubMed ID: 10564752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic effect of Epstein-Barr virus and tumor promoters on induction of lymphoma and carcinoma in nude mice.
    Liu Z; Liu Y; Zeng Y
    J Cancer Res Clin Oncol; 1998; 124(10):541-8. PubMed ID: 9829857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequent detection of Epstein-Barr virus-infected B cells in peripheral T-cell lymphomas.
    Ho JW; Ho FC; Chan AC; Liang RH; Srivastava G
    J Pathol; 1998 May; 185(1):79-85. PubMed ID: 9713363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus-positive B-cell lymphoma of the elderly at a United States tertiary medical center: an uncommon aggressive lymphoma with a nongerminal center B-cell phenotype.
    Gibson SE; Hsi ED
    Hum Pathol; 2009 May; 40(5):653-61. PubMed ID: 19144386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model but Are Not Essential.
    Ma SD; Tsai MH; Romero-Masters JC; Ranheim EA; Huebner SM; Bristol JA; Delecluse HJ; Kenney SC
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28077657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies of HIV infection and the development of Epstein-Barr virus-related B cell lymphomas following transfer of human lymphocytes to mice with severe combined immunodeficiency.
    Mosier DE; Gulizia RJ; Baird SM; Spector S; Spector D; Kipps TJ; Fox RI; Carson DA; Cooper N; Richman DD
    Curr Top Microbiol Immunol; 1989; 152():195-9. PubMed ID: 2553338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus-associated primary central nervous system lymphomas in immunocompetent elderly patients: analysis for latent membrane protein-1 oncogene deletion and EBNA-2 strain typing.
    Sugita Y; Terasaki M; Niino D; Ohshima K; Fumiko A; Shigemori M; Sato Y; Asano N
    J Neurooncol; 2010 Nov; 100(2):271-9. PubMed ID: 20455004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.